Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 569.95
-5.35 (-0.93%)
Sep 11, 2026, 3:30 PM IST
Blue Jet Healthcare Revenue
Blue Jet Healthcare had revenue of 2.93B INR in the quarter ending June 30, 2026, a decrease of -17.38%. This brings the company's revenue in the last twelve months to 8.86B, down -27.51% year-over-year. In the fiscal year ending March 31, 2026, Blue Jet Healthcare had annual revenue of 9.47B, down -8.03%.
Revenue (ttm)
8.86B
Revenue Growth
-27.51%
P/S Ratio
12.15
Revenue / Employee
15.24M
Employees
581
Market Cap
107.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.47B | -826.64M | -8.03% |
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 173.21B |
| Dishman Carbogen Amcis | 29.01B |
| Anthem Biosciences | 20.07B |
| OneSource Specialty Pharma | 15.43B |
| Concord Biotech | 11.08B |
| Supriya Lifescience | 8.73B |
| Panacea Biotec | 6.73B |
| Zota Health Care | 6.09B |